Evidence map›Paper›PMID 41540114›Full record

ReviewNature protocols2026

Profiling active RNA polymerase II transcription start sites from total RNA by capped small RNA sequencing (csRNA-seq).

Mackenzie K Meyer, Oluwadamilola J Olanrewaju, Patricia Montilla-Perez, Anna L McDonald, Eva M Rickard, Francesca Telese, Christopher Benner, Marina I Savenkova, Sascha H Duttke

Abstract readReview
In one paragraph

Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mackenzie K MeyerSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.ORCID 0009-0003-1951-8088
Oluwadamilola J OlanrewajuSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.ORCID 0009-0007-4177-5805
Patricia Montilla-PerezDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Anna L McDonaldSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.ORCID 0000-0003-0107-8507
Eva M RickardSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.ORCID 0009-0006-1177-410X
Francesca TeleseDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Christopher BennerDepartment of Medicine, Division of Endocrinology, University of California San Diego School of Medicine, La Jolla, CA, USA.
Marina I SavenkovaSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.
Sascha H DuttkeSchool of Molecular Biosciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA. sascha.duttke@wsu.edu.ORCID 0000-0003-4717-000X

Funding

Decoding the grammar of transcriptional enhancers regulating different stages of opioid use disorderU01DA051972 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENNER, CHRISTOPHER W, TELESE, FRANCESCA · 2020 to 2024
$3.4M
Training in Biotechnology: Emphasis in Protein ChemistryT32GM152310 · NIGMS · WASHINGTON STATE UNIVERSITY · PI Bernd Markus Lange · 2024 to 2026
$1.6M
Multiscale genomic decryption of regulatory DNAR35GM149520 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christopher W Benner · 2024 to 2026
$1.2M
Exploiting Natural Genetic and Organismic Variation to Identify the DNA Motifs Regulating TranscriptionR00GM135515 · NIGMS · WASHINGTON STATE UNIVERSITY · PI DUTTKE, SASCHA H. · 2022 to 2024
$747k
NIDA NIH HHS U01 DA051972NIGMS NIH HHS R00 GM135515NIGMS NIH HHS R35 GM149520NIGMS NIH HHS T32 GM152310U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R00GM135515U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM152310U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) U01DA051972
6 · The paper itself

Abstract

High-resolution mapping of active RNA polymerase II transcription initiation provides a dynamic view of gene expression and reveals the entire spectrum of RNA transcripts-from stable mRNAs to transient enhancer RNAs-which is critical for understanding gene regulation, deciphering transcriptional programs and defining regulatory element function. Here we present a detailed protocol for capped small RNA sequencing (csRNA-seq). Starting with total RNA, which can be readily isolated from fresh, frozen or fixed cells, tissues or patient samples, csRNA-seq selectively enriches for actively initiating 5'-capped RNA polymerase II transcripts. This approach captures both initiating stable protein-coding RNAs and non-coding RNAs, as well as rapidly degraded, transient transcripts such as enhancer or promoter divergent RNAs, providing a comprehensive snapshot of active cis-regulatory elements and facilitating the study of underlying regulatory mechanisms with high sensitivity. The protocol involves small RNA isolation, 5'-capped RNA enrichment and library generation, followed by sequencing. Key advantages of csRNA-seq over other nascent RNA-seq methods include (i) decoupling of sample collection and processing, (ii) broad compatibility with diverse eukaryotic sample types and organisms, (iii) high-resolution data defining active regulatory elements and their properties and (iv) scalability. Importantly, purified RNA is non-infectious and can be isolated from inactivated samples, including clinical or pathogenic specimens, allowing safe transport and analysis under standard laboratory conditions. This protocol empowers researchers with minimal experience in nascent transcriptomics to study gene regulation, cis-regulatory elements and transcription dynamics.

Indexed as

RNARNA CapsRNA Polymerase IIRNA, Small CytoplasmicSequence Analysis, RNATranscription Initiation SiteAnimalsHumansTranscription, GeneticRNARNA CapsRNA Polymerase IIRNA, Small Cytoplasmic

Identifiers

PMID41540114
PMCPMC12994261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.